en

PRODUCT DETAIL

MEDOVIR 250 mg prášok na infúzny roztok

Code 6626D
MA number 42/0036/21-S
Product Form: plv ifo 10x250 mg (liek.inj.skl.)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
Therapeutic Class: 42 - CHEMOTHERAPEUTICA (VRATANE TUBERKULOSTATIK)
ATC:
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AB Nucleosides and nucleotides excl. reverse transcriptase
J05AB01 Aciclovir
Shelf life: 48
Container: glass vial
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 17.02.2021
Validity: 17.02.2026
Pediatric posology: Yes
PIL: PIL_MEDOVIR 250 mg_plv ifo_04.2021.pdf  
SPC: SPC_MEDOVIR 250 mg_plv ifo_04.2021.pdf  
Safety feature Yes
Data update: 01.03.2021
eu-flag.png sk-flag.png